Literature DB >> 6278084

Opiate receptor-mediated inhibition of adenylate cyclase in rat striatal plasma membranes.

D M Cooper, C Londos, D L Gill, M Rodbell.   

Abstract

Plasma membranes from rat striatum contain adenylate cyclase activity that is subject to dual regulation by GTP. Low concentrations (up to 30 nM) of the nucleotide increase activity whereas higher concentrations evoke a steady decline in activity; such behavior characterizes dually regulated adenylate cyclase systems. The opiates, morphine sulfate and D-Ala-Met-enkephalin, produce naloxone-reversible inhibition of the enzyme that is dependent on "inhibitory concentrations" of GTP (above 50 nM). In the absence of GTP no inhibition is observed. Sodium ions decrease the inhibition of activity promoted by GTP alone, but amplify the degree of inhibition seen in the presence of the opiates and GTP. The potencies of the opiates in mediating these effects mirror their affinities for delta opiate receptors in striatum. It is suggested that this action of the opiates may represent their primary action in striatum.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6278084     DOI: 10.1111/j.1471-4159.1982.tb05365.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  Mu and delta receptors belong to a family of receptors that are coupled to potassium channels.

Authors:  R A North; J T Williams; A Surprenant; M J Christie
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

2.  Molecular control of δ-opioid receptor signalling.

Authors:  Gustavo Fenalti; Patrick M Giguere; Vsevolod Katritch; Xi-Ping Huang; Aaron A Thompson; Vadim Cherezov; Bryan L Roth; Raymond C Stevens
Journal:  Nature       Date:  2014-01-12       Impact factor: 49.962

3.  Comparison of the effects of [leucine]enkephalin and angiotensin on hepatic carbohydrate and cyclic nucleotide metabolism.

Authors:  S K Hothi; R P Leach; M A Titheradge
Journal:  Biochem J       Date:  1988-02-01       Impact factor: 3.857

4.  Allosteric Coupling of Drug Binding and Intracellular Signaling in the A2A Adenosine Receptor.

Authors:  Matthew T Eddy; Ming-Yue Lee; Zhan-Guo Gao; Kate L White; Tatiana Didenko; Reto Horst; Martin Audet; Pawel Stanczak; Kyle M McClary; Gye Won Han; Kenneth A Jacobson; Raymond C Stevens; Kurt Wüthrich
Journal:  Cell       Date:  2017-12-28       Impact factor: 41.582

Review 5.  Harnessing Ion-Binding Sites for GPCR Pharmacology.

Authors:  Barbara Zarzycka; Saheem A Zaidi; Bryan L Roth; Vsevolod Katritch
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

6.  Mechanisms for increased adenylate cyclase responsiveness to TSH in neoplastic human thyroid tissue.

Authors:  O H Clark; P L Gerend; R A Nissenson
Journal:  World J Surg       Date:  1984-08       Impact factor: 3.352

7.  Inhibition of dopamine-activated adenylate cyclase and dopamine binding by opiate receptors in rat striatum.

Authors:  S Gentleman; M Parenti; N H Neff; C B Pert
Journal:  Cell Mol Neurobiol       Date:  1983-03       Impact factor: 5.046

8.  Opioid inhibition of adenylate cyclase in the striatum and vas deferens of the rat.

Authors:  K D Bhoola; S Pay
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

9.  Inhibition of adenylate cyclase in rat brain synaptosomal membranes by GTP and phenylisopropyladenosine is enhanced in hypothyroidism.

Authors:  D Mazurkiewicz; E D Saggerson
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

10.  Dopamine depletion augments endogenous opioid-induced locomotion in the nucleus accumbens using both mu 1 and delta opioid receptors.

Authors:  L Churchill; B P Roques; P W Kalivas
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.